Literature DB >> 2301661

Emergence of intense suicidal preoccupation during fluoxetine treatment.

M H Teicher1, C Glod, J O Cole.   

Abstract

Six depressed patients free of recent serious suicidal ideation developed intense, violent suicidal preoccupation after 2-7 weeks of fluoxetine treatment. This state persisted for as little as 3 days to as long as 3 months after discontinuation of fluoxetine. None of these patients had ever experienced a similar state during treatment with any other psychotropic drug.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2301661     DOI： 10.1176/ajp.147.2.207

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  77 in total

1.  Violent acts associated with fluvoxamine treatment.

Authors:  F Okada; K Okajima
Journal:  J Psychiatry Neurosci       Date:  2001-09       Impact factor: 6.186

Review 2.  Pharmacological treatment of depression in children and adolescents.

Authors:  R L Findling; M D Reed; J L Blumer
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

3.  Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion.

Authors:  Donna S Wightman; Vicki J Foster; Alok Krishen; Nathalie E Richard; Jack G Modell
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 4.  Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned?

Authors:  Robert D Gibbons; J John Mann
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

Review 5.  Antidepressants and suicide: risk-benefit conundrums.

Authors:  David Healy; Chris Whitaker
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

Review 6.  Suicidality with selective serotonin reuptake inhibitors: Valid claim?

Authors:  Yvon D Lapierre
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

7.  In the grip of the python: conflicts at the university-industry interface.

Authors:  David Healy
Journal:  Sci Eng Ethics       Date:  2003-01       Impact factor: 3.525

Review 8.  The safety of antidepressants.

Authors:  F de Jonghe; J A Swinkels
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 9.  Antidepressants and suicide: what is the balance of benefit and harm.

Authors:  David Gunnell; Deborah Ashby
Journal:  BMJ       Date:  2004-07-03

10.  Development and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment Profile.

Authors:  Jeannette M Reid; Eric A Storch; Tanya K Murphy; Danielle Bodzin; P Jane Mutch; Heather Lehmkuhl; Michael Aman; Wayne K Goodman
Journal:  Child Youth Care Forum       Date:  2010-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.